[A familial case of prostate cancer in three brothers].
نویسندگان
چکیده
We treated three brothers for prostate cancer. The first brother developed the disease of poorly differentiated adenocarcinoma at the age of 76, and was treated with endocrine therapy but died of recurrent cancer at age 80. The second brother was diagnosed poorly differentiated adenocarcinoma at age 75, and he is alive at age 80 without recurrence after endocrine therapy. The third brother developed moderately differentiated adenocarcinoma at age 58, and was treated with endocrine therapy but died of recurrent cancer at age 73. We have seen few familial cases of prostate cancer. The first such case is reported here in Japan. Eleven similar cases of familial prostate cancer involving three or more brothers have been reported in the Western literature.
منابع مشابه
غربالگری کانسر پروستات در افراد بالای 40 سال با سابقه فامیلی مثبت
Background and purpose: Prostate cancer is one of the most prevalent diseases among men. The role of heredity in prostate cancer has been proved by epidemiologic studies. By utilization of prostate specific antigen (PSA) and digital rectal exam (DRE) we could diagnose the disease before the clinical manifestation and implement screening programs. The purpose of this study was to screen the pros...
متن کاملFAMILIAL COLLOID CYST OF THE THIRD VENTRICLE: A CASE REPORT AND REVIEW OF THE LITERATURE
Familial colloid cyst of the third ventricle is very rare. This is one of the two largest families reported and the first in which all affected members are siblings. One asymptomatic sister was found by screening, emphasizing the value of screening. A brother and two sisters from a family consisting of three brothers and three sisters who were diagnosed as having colloid cyst of the third v...
متن کاملژنتیک مولکولی، تشخیص، پیشگیری و ژن درمانی در سرطان پروستات: مقاله مروری
The prostate is a small gland located below the bladder and upper part of the urethra. In developed countries prostate cancer is the second common cancer (after skin cancer), and also the second leading cause of cancer death (after lung cancer) among men. The several studies have been shown prostate cancer familial aggregation. The main reason for this aggregation is inheritance included genes....
متن کاملSequenceVariation ina-Methylacyl-CoARacemase andRiskof Early-Onset and Familial ProstateCancer
BACKGROUND. Expression of the a-methylacyl-CoA racemase (AMACR) gene has been established as a sensitive and specific biomarker for the diagnosis of prostate cancer. An initial study has also suggested that the risk of familial (but not sporadic) prostate cancer may be associated with germline variation in the AMACR gene. METHODS. In a study of brothers discordant for the diagnosis of prostate ...
متن کاملAge-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members.
BACKGROUND The thorough assessment of familial prostate cancer (PCa) risk is as important as ever to provide a basis for clinical counselling and screening recommendations. OBJECTIVE Our aim was to determine the age-specific risks of PCa and the risk of death from PCa according to the number and the age of affected first-degree relatives. DESIGN, SETTING, AND PARTICIPANTS The nationwide Swe...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Nihon Hinyokika Gakkai zasshi. The japanese journal of urology
دوره 85 11 شماره
صفحات -
تاریخ انتشار 1994